Concert Genetic Testing: Eye Disorders V1.2025
Customize your policy alerts
Sign up for all Community Health Plan Washington policy alerts
Know when Community Health Plan Washington releases new policies or updates existing guidance.
Monitor payer policy activity
Defines medical necessity, investigational status, and criteria for genetic testing for macular degeneration, inherited retinal dystrophies, and other genetically-associated eye disorders for members of the payer network.
Macular Degeneration: Removed CPT code 81406 from Fulgent Genetics test in Policy Reference Table and within criteria.
Clinical criteria for Inherited Retinal Dystrophies Multigene Panel Analysis were updated and the criteria set name changed (formerly 'RPE65 Sequencing and/or Deletion/Duplication Analysis').
Other Covered Eye Disorders: Removed 'Retinitis Pigmentosa' from disorders list (covered under Inherited Retinal Dystrophies criteria).
A glaucoma-related criteria set was retired due to low order and claim volume.
Inherited Retinal Dystrophies Multigene Panel Analysis: updated access date for online reference.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.